Contact Form

Name

Email *

Message *

Cari Blog Ini

Doh Interim Guidelines Issued In 2022

```html

Mpox: DOH Says Current Guidelines Sufficient to Protect Public

DOH: Interim Guidelines Issued in 2022

In response to the ongoing mpox outbreak, the Department of Health (DOH) has stated that the current health guidelines are adequate in safeguarding the public. According to the DOH, interim technical guidelines for mpox surveillance, screening, management, and infection control were issued in 2022.

DOH Urges Caution

While the DOH believes that the existing guidelines are sufficient, it has emphasized the importance of caution and adherence to preventive measures. The department has advised the public to remain vigilant and to seek medical attention immediately if they experience any symptoms of mpox.

Mpox Symptoms

  • Fever
  • Body aches
  • Skin lesions

Vaccination Recommendations

According to the Centers for Disease Control and Prevention (CDC), individuals who have been exposed to mpox, or suspect they have been exposed, should receive vaccination. The CDC also recommends vaccination for individuals at high risk of exposure, such as healthcare workers and laboratory personnel.

WHO Framework for Mpox Prevention

The World Health Organization (WHO) has recently released a framework to guide health authorities, communities, and stakeholders in preventing and responding to the mpox outbreak. The framework emphasizes the importance of:

  • Surveillance and early detection
  • Infection prevention and control
  • Risk communication and community engagement

Conclusion

The DOH's assurance that current health guidelines are sufficient to protect the public from the mpox outbreak provides a sense of reassurance. However, it is crucial for individuals to remain vigilant, adhere to preventive measures, and seek medical attention if they experience any symptoms of the disease. By following these guidelines, we can collectively contribute to containing the spread of mpox and protect the health of our communities.

```


Comments